Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
Thursday, July 02, 2026Novartis today announced that the European Commission EC has approved Itvisma onasemnogene abeparvovec for the treatment of children two years and older teens and adults living with q spinal muscular
Turkish Cargo has been Selected as the “Cargo Airline of the Year – Global” for the Second Consecutive Time
Thursday, July 02, 2026Turkish Airlines global air cargo brand Turkish Cargo was awarded Cargo Airline of the Year Global for the second consecutive time at the World Air Cargo Awards organized by Air Cargo Week
Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing
Wednesday, July 01, 2026Lonza the worlds leading contract development and manufacturing organization CDMO today announced plans to enhance its druglinker center of excellence and expand payloadlinker manufacturing capacity at its Visp site
Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio
Wednesday, July 01, 2026Ipsen and Memo Therapeutics AG announced today they have entered into a definitive share purchase agreement under which Ipsen has agreed to acquire all issued and outstanding shares of Memo Therapeutics AG
Lonza Expands HPAPI Capacity in Visp, Further Supporting its Position in Payload-Linker Manufacturing
Tuesday, June 30, 2026Lonza the worlds leading contract development and manufacturing organization CDMO today announced plans to enhance its druglinker center of excellence and expand payloadlinker manufacturing capacity at its Visp site
Roche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform
Monday, June 29, 2026Roche announced today the launch of AXELIOS based on the innovative SBX technology with a unique combination of accuracy speed flexibility scalability and cost efficiency that addresses critical bottlenecks in genomics
Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China
Monday, June 29, 2026Everest Medicines today announced that Chinas National Medical Products Administration NMPA accepted the Biologics License Application BLA for LEROCHOLR lerodalcibep a thirdgeneration PCSK inhibitor
TolerogenixX Completes Last Patient Transplant in Phase IIb TOL-2 Trial of MIC-Lx, Advancing a New Immune Tolerance Approach in Kidney Transplantation
Monday, June 29, 2026TolerogenixX a clinicalstage biopharmaceutical company founded in developing personalized cell therapies to induce antigenspecific immune tolerance today announced that the last patient has undergone
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing
Thursday, June 25, 2026ALZpath Inc the leader in blood testbased diagnostic solutions for Alzheimers disease today announced a licensing agreement with Abbott NYSE ABT a global healthcare leader to incorporate ALZpaths proprietary
European Commission Approves Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors
Wednesday, June 24, 2026Gilead Sciences Inc Nasdaq GILD today announced that the European Commission EC has granted marketing authorization for Trodelvy sacituzumab govitecanhziy as monotherapy for the treatment of adult
